Table 2.
Certainty assessment | № of patients | Effect | Certainty | Importance | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
№ of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | lubricants during or prior to sex | no lubricants | Relative (95% CI) | Absolute (95% CI) | ||
1. Vaginal dryness or pain during vaginal/anal penetration:Experience of pain during last insertive partnered sexual event (assessed with: self-report) | ||||||||||||
117 | Observational studies | Seriousa | Not seriousb | Not serious | Seriousc | None | 11/61 (18.0%) | 3/21 (14.3%) | RR 1.26 (0.39–4.09) | 37 more per 1000 (from 87 fewer to 441 more) | ⊕◯◯◯ VERY LOW | CRITICAL |
1. Vaginal dryness or pain during vaginal/anal penetration:Experience of pain during last receptive partnered sexual event (assessed with: self-report) | ||||||||||||
117 | Observational studies | Very seriousa,d | Not seriousb | Not serious | Not serious | None | 45/71 (63.4%) | 3/17 (17.6%) | RR 3.59 (1.27–10.18) | 457 more per 1000 (from 48 more to 1000 more) | ⊕◯◯◯ VERY LOW | CRITICAL |
1. Vaginal dryness or pain during vaginal/anal penetration:Degree of pain during last insertive partnered sexual event (assessed with: self-report, higher score indicates greater pain) | ||||||||||||
117 | Observational studies | Seriousa | Not seriousb | Not serious | Not serious | None | 2.3 | 2.9 | MD 0.6 lower | ⊕◯◯◯ VERY LOW | CRITICAL | |
1. Vaginal dryness or pain during vaginal/anal penetration: Degree of pain during last receptive partnered sexual event (assessed with: self-report, higher score indicates greater pain) | ||||||||||||
117 | Observational studies | Seriousa | Not seriousb | Not serious | Not serious | None | 2.2 | 3 | MD 0.8 lower | ⊕◯◯◯ VERY LOW | CRITICAL | |
1. Vaginal dryness or pain during vaginal/anal penetration:Dyspareunia (assessed with: visual analogue score pain assessment of dyspareunia, lower score is better outcome; Scale from: 0–10) | ||||||||||||
14 | Observational studies | Seriousa | Not seriousb | Not serious | Seriouse | None | 2.7 | 7 | MD 4.3 lower | ⊕◯◯◯ VERY LOW | CRITICAL | |
1. Vaginal dryness or pain during vaginal/anal penetration:Sexual discomfort (assessed with: Sexual Activity Questionnaire – Discomfort subscale assessing vaginal dryness and dyspareunia, higher score is better outcome; Scale from: 0–6) | ||||||||||||
14 | Observational studies | Seriousa | Not seriousb | Not serious | Seriouse | None | 2.9 | 0.8 | MD 2.1 higher | ⊕◯◯◯ VERY LOW | CRITICAL | |
3. Sexual desire, arousal, lubrication, orgasm, satisfaction, and pleasure:Female sexual well-being (assessed with: FSWB scale overall score) | ||||||||||||
120 | Randomised trials | Seriousf | Not seriousb | Not serious | Not serious | None | Least-squares mean change in score from baseline vs end of study: Couple lubricant (n = 80) vs no lubricant (n = 82): 6.35 vs 1.94; Female lubricant (n = 82) vs no lubricant (n = 82): 3.99 vs 1.94g | ⊕⊕⊕⃝ MODERATE | IMPORTANT | |||
6. STIs/HIV:HPV incidence (one or more new HPV type(s) detected, among participants with no HPV detected at baseline) (follow up: mean 12 months; assessed with: PCR for HPV consensus probe) | ||||||||||||
121 | Randomised trials | Not serioush | Not seriousb | Not serious | Seriousc | None | 120/593 (20.2%) | 131/587 (22.3%) | RR 0.91 (0.73–1.13) | 20 fewer per 1000 (from 60 fewer to 29 more) | ⊕⊕⊕⃝ MODERATE | IMPORTANT |
6. STIs/HIV:HPV incidence (one or more new oncogenic HPV type(s) detected, among participants with no HPV detected at baseline) (follow up: mean 12 months; assessed with: PCR for HPV consensus probe) | ||||||||||||
121 | Randomised trials | Not serioush | Not seriousb | Not serious | Seriousc | None | 56/593 (9.4%) | 51/587 (8.7%) | RR 1.09 (0.76–1.56) | 8 more per 1000 (from 21 fewer to 49 more) | ⊕⊕⊕⃝ MODERATE | IMPORTANT |
Notes: CI: Confidence interval; RR: Risk ratio; MD: Mean difference; FSWB: Female sexual well-being; PCR: Polymerase chain reaction; HPV: Human papillomavirus.
Risk of bias: Certainty of evidence downgraded for self-report of pain.
Inconsistency: This could not be evaluated, as there is only a single study.
Imprecision: Certainty of evidence downgraded because 95% CI for RR includes both 1 (no effect) AND either appreciable harm (0.75) or appreciable benefit (1.25).
Risk of bias: Participants who reported using lubricant during their last partnered event were asked to indicate their reasons for using lubricant. The most highly endorsed statement (89.3%) was that lubricant reduced their pain/discomfort. This may indicate reverse causation between lubricant use and experience of pain.
Imprecision: Certainty of evidence downgraded due to small sample size (n = 25).
Risk of bias: Certainty of evidence downgraded for detection bias. Blinding was not possible given the nature of the intervention, and outcome may have been affected by lack of blinding.
FSWB scale includes subscales, whose results (least-squares mean change in score from baseline vs end of study) are presented in this footnote.
Interpersonal domain: Couple lubricant (n = 80) vs no lubricant (n = 82): 1.80 vs 0.13; Female lubricant (n = 82) vs no lubricant (n = 82): 1.32 vs 0.13.
Cognitive-emotional domain: Couple lubricant (n = 80) vs no lubricant (n = 82): 2.48 vs 1.08; Female lubricant (n = 82) vs no lubricant (n = 82): 1.67 vs 1.08.
Physical arousal domain: Couple lubricant (n = 80) vs no lubricant (n = 82): 0.81 vs 0.72; Female lubricant (n = 82) vs no lubricant (n = 82): 0.07 vs 0.72.
Orgasm satisfaction domain: Couple lubricant (n = 80) vs no lubricant (n = 82): 1.43 vs 0.01; Female lubricant (n = 82) vs no lubricant (n = 82): 1.04 vs 0.01.
Risk of bias: Certainty of evidence not downgraded for detection bias. Blinding was not possible given the nature of the intervention, but outcome unlikely to have been affected by lack of blinding.